Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...

CytoSorbents Corp (CTSO) reports an 11% increase in product sales and a significant reduction in operating loss, while ...

Let's look at five biotech and drug companies, AZN, NVAX, AXSM, TBPH and PRTA, slated to release their third-quarter 2024 ...

The US Food and Drug Administration has FDA has granted marketing authorization to a form of light therapy as the first-ever ...

Fisher Asset Management's portfolio value increased to $244B, with top holdings in Apple, Microsoft, Nvidia, Amazon, and ...

European equities traded in the US as American depositary receipts were tracking sharply lower late Tuesday morning, declining 1.71% to 1,313.74 on the S&P Europe Select ADR Index. From continental ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

Personalized repetitive transcranial magnetic stimulation slowed cognitive and functional impairment in a phase 2 study of ...